Epigenetics Market | Size | Share | Global Industry Report 2018 - 2024
Added: (Fri Feb 08 2019)
Pressbox (Press Release) -
A Global Report On Epigenetics Market With Analysis And Past, Present And Future Trends
Epigenetics are emerged as to include any process that alters gene activity without changing the DNA sequence. It is basically a study of heritable changes in gene expression which involves the change in phenotype without changing genotype. Epigenetic changes are affected by various factors like lifestyle, environment, age and state of disease. Epigenetic modifications can manifest a common manner of cells which differentiate terminally to end up as liver cells, skin cells, brain cells etc. Epigenetic change may have more damaging effects which can lead to diseases like cancer.
Request Sample Report : https://precisionbusinessinsights.com/request-sample?product_id=17020
The surge in the prevalence of cancer, improving funds and aids for the R&D activities, rise in the partnerships between pharmaceutical and biotechnology companies and research institutes, increase in epigenetics application in non-oncology diseases will propel the epigenetics drug market. Moreover, improved advancements in epigenetics technology, untapped potential of emerging markets like India and China are expected to offer many opportunities for the growth of epigenetics research market. However, high instrument cost and the paucity of skilled personnel are expected to hamper the growth of the epigenetics drug market.
The global Epigenetics market is classified on the basis of following categories-
1. Enzymes
• DNA polymerase
• Acetylases
• DNA ligases
• Methyltransferase
• RNA ligases
• Reverse Transcriptase
• Others
2. Instruments
• Next generation sequencers
• Mass spectrometers
• Sonicators
• qPCRs
• Others
3. Applications
• Oncology
• Cardiovascular diseases
• Metabolic diseases
• Inflammatory diseases
• Infectious diseases
4. Kits and assays
• Deep sequencing kit
• Bisulfate conversion kit
• Methyltransferase assays
• Chip- sequence kits
• Immunoprecipitation kits
• Histone assay
5. End-users
Pharmaceutical and biotechnological companies, Contract research companies and Academic and Research Institutes.
And lastly, on the basis of geographical regions, the global Epigenetics market have five major regions- Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America holds the largest share in epigenetics drug market due to rise in prevalence of cancer, high funding on R&D, increasing acquisitions and collaborations among large pharma companies, high adaptation and awareness of new technologies and healthcare infrastructure. Asia Pacific is a lucrative market owing to the presence of favorable regulatory framework, high incidence and prevalence of diabetes, cancer and cardiovascular diseases among the population of Asia Pacific countries. Some of the key players in epigenetics research market Illumina, Inc. (U.S.), Abcam plc. (U.K), QIAGEN N.V. (Netherland), New England Biolabs, Inc. (U.S.), Merck & Co. (U.S.), Sigma-Aldrich Corporation (U.S.), Genedata AG(Switzerland), Active Motif (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Diagenode, Inc. (Belgium), and Episona Inc. (U.S).In 2016, an epigenetics data company launched SEED a novel male fertility test to evaluate epigenetic changes on DNA to detect a risk of infertility and poor embryo development.
Epigenetics has triggered R&D for new drugs for various cancers, chronic and autoimmune disorders. Introduction of advanced technologies and potential investments on R&D activities are expected to fuel the growth of epigenetics. The epigenetics market report shows that companies are focusing on detection of DNA methylation patterns and histone modification. Development of high specific antibodies for accurate and rapid detection of modifications of histone core proteins.
For More Information : https://precisionbusinessinsights.com/market-reports/global-epigenetics-market/